Psyched: Compass Joins Nasdaq, Field Trip Goes Public, MindMed Begins Trials, ATAI Launches MDMA Subsidiary
'Psyched': FDA Expands Indications For Ketamine, MindMed Launches Subsidiary, John Hopkins Begins 'Real-World' Study
Psyched: Compass Joins Nasdaq, Field Trip Goes Public, MindMed Begins Trials, ATAI Launches MDMA Subsidiary
'Psyched': FDA Expands Indications For Ketamine, MindMed Launches Subsidiary, John Hopkins Begins 'Real-World' Study
'Psyched': Psychedelics Measure DC Ballot, GreenStar Buys Eleusian, MindMed Wraps Clinical Trial
'Psyched': Silo Wellness To Go Public, MindMed Adds DMT To Research Portfolio, Champignon Closes $11M Raise, Mydecine Launches New Research Partnership
'Psyched': Psychedelics Measure DC Ballot, GreenStar Buys Eleusian, MindMed Wraps Clinical Trial
'Psyched': Silo Wellness To Go Public, MindMed Adds DMT To Research Portfolio, Champignon Closes $11M Raise, Mydecine Launches New Research Partnership
MindMed To Begin Clinical Trials On Ayahuasca's Active Ingredient DMT
'Psyched': New Leaf Brands Changes Name To Mydecine, Numinus Debuts On TSXV, MindMed To Research MDMA-LSD Interactions
Mind Medicine Inc. Recent News
'Psyched': ATAI Closes $24M Convertible Round, MindMed To Begin Trading On OTCQB, Investor Presentations Available Online
'Psyched': MindMed Acquires Rights For LSD Research, NewLeaf Brands To Purchase Mushroom Company
MindMed Inks Deal With Switzerland University For Rights On LSD Research
MindMed Lists On NEO Exchange, Becomes First Psychedelics Company To Go Public